Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Minimally invasive characterization of peripheral blood measurable residual disease in myeloma by high-sensitivity detection of ctDNA by NGS shows higher positive predictive value (88.9% vs. 34.5%) for relapse vs. BM NGF.”
Title: Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing
Authors: Natalia Buenache, Marta Lasa, Andrés Arroyo, Carmen González, Larissa Haertle, Yanira Ruiz-Heredia, Rosa Ayala, Rafael Alonso, Alejandro Martín-Muñoz, Juan Rosa-Rosa, Verónica González, María Calasanz, Paula Rodríguez-Otero, Laura Rosiñol, Felipe De Arriba, Enrique Ocio, Albert Oriol, Yolanda González, Anna Sureda, Sunil Lakhwani, María Clavero, Angela Ibáñez, Clara Gómez, Alberto Orfao, María-Victoria Mateos, Juan Lahuerta, María Cedena, Joan Bladé, Jesús San Miguel, Noemi Puig, Bruno Paiva, Joaquín Martínez-Lópe
You can read the Full Article on HemaSphere.
You can find other articles featuring Robert Orlowski on OncoDaily.
